ArticleCancer research communications2026
Peptide-Reactive T-cell Response as a Novel Biomarker in Patients with Head and Neck Cancer Treated with Anti-PD-1 Antibody.
Takumi Kumai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.